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Abstract
Bacterial pathogens have evolved a specialized type III secretion system (T3SS) to translocate virulence effector proteins
directly into eukaryotic target cells. Salmonellae deploy effectors that trigger localized actin reorganization to force their
own entry into non-phagocytic host cells. Six effectors (SipC, SipA, SopE/2, SopB, SptP) can individually manipulate actin
dynamics at the plasma membrane, which acts as a ‘signaling hub’ during Salmonella invasion. The extent of crosstalk
between these spatially coincident effectors remains unknown. Here we describe trans and cis binary entry effector interplay
(BENEFIT) screens that systematically examine functional associations between effectors following their delivery into the
host cell. The results reveal extensive ordered synergistic and antagonistic relationships and their relative potency, and
illuminate an unexpectedly sophisticated signaling network evolved through longstanding pathogen–host interaction.
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Introduction
Many bacterial pathogens employ type III secretion systems
(T3SSs) to deliver virulence effector proteins directly into
eukaryotic host cells [1]. An essential early T3SS-dependent step
in Salmonella pathogenesis is bacterial invasion of non-phagocytic
intestinal epithelial cells, an event that can be modelled using
cultured cells [2]. Invading bacteria deliver effectors that induce
actin-rich membrane ruffles, which drive pathogen internalization
into a membrane-bound vacuole where they subsequently survive
and replicate [3].
Effectors are delivered into the target cell via a cholesterol-
binding plasma membrane-integral translocon comprising SipB
and SipC, which is likely linked to the T3SS by SipD [4,5]. Six
delivered effectors manipulate the target cell actin cytoskeleton
(summarized in Figure 1A). Two Salmonella actin-binding
proteins, SipC and SipA, control actin dynamics directly [6]. In
addition to its role in effector delivery, discrete SipC domains
nucleate actin polymerization and bundle actin filaments (F-actin)
[7]. Both these SipC-directed activities are stimulated by SipA [8],
which itself binds and stabilizes F-actin and suppresses actin
turnover by host ADF/cofilin and gelsolin [9,10]. Further effectors
stimulate Rho-family GTPase signaling to induce cytoskeletal and
nuclear responses [11]. The guanine nucleotide exchange factor
mimic SopE (or ubiquitous SopE2) activates Cdc42 and Rac1
GTPases directly [12–14], whereas the inositol polyphosphatase
SopB/SigD stimulates Cdc42, Rac-1 and the cellular RhoG SH3-
containing guanine nucleotide exchange factor (SGEF) through
induced phosphoinositide fluxes [12,15,16]. After invasion, Rho
GTPase up regulation is antagonized by SptP, a GTPase
activating protein (GAP) mimic and tyrosine phosphatase [17].
Discrete bacterial surface proteins of Listeria and Yersinia induce
internalization by hijacking host receptor-mediated endocytosis
[18]. In contrast, individual Salmonella effectors are insufficient to
promote bacterial internalization, although SopE, SopB and SipC
do elicit generalized cell-wide cytoskeletal reorganization and
membrane protrusions when expressed individually in cells
[8,14,19,20]. It is likely that delivered effectors must therefore
act in concert to induce productive actin rearrangements rapidly
and specifically beneath invading Salmonellae without compromis-
ing target cell viability [6,11].
We have previously demonstrated that Salmonella entry effectors
localize to the target cell plasma membrane both when expressed
individually in cultured cells and after delivery via the bacterial
T3SS, and consequently we proposed the plasma membrane as a
critical interface for Salmonella effector action [19]. We next
explored how the activities of these spatially co-incident effectors
might potentially be coordinated to trigger actin rearrangements.
Here we describe systematic experimental screens that illuminate
the extent, potency and hierarchy of interplay between Salmonella
effectors and their host targets within cultured cells.
Results
Only effectors delivered by the Salmonella T3SS promote
invasion
To investigate the subcellular localization of effectors delivered
by the invasion-associated Salmonella T3SS [19], we generated a
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bank of wild-type (WT) S.typhimurium SL1344 strains each
additionally expressing an individual plasmid-encoded epitope-
tagged entry effector. This allowed the expression, secretion
and delivery of an individual effector to be specifically enhanced
(1.5–3.3-fold WT) in a WT background (described in detail in
Materials and Methods and [19]). Hereafter, these WT strains
engineered to deliver increased doses of particular effectors are
termed ‘effector-augmented strains’, and the enhanced effector as
‘d-effector’.
When cultured cells were infected with the effector-augmented
strains (Figure 1B, left), we observed that a significant increase in
bacterial invasion rate occurred with the dSopE, dSopB or dSipC
strains (Figure 1B, right ,300%; i.e. an approximately 3-fold
increase compared to WT normalized to 100%). Each of these
strains secrete the other entry effectors at WT levels [19], but since
SipC additionally functions in effector translocation in complex
with SipB [7], we additionally investigated the effect of enhancing
the levels of the other translocation-associated effectors SipB and
SipD (Figure S1A). In contrast to the dSipC strain, no significant
increase in invasion rate occurred upon infection with effector-
augmented dSipB or dSipD strains (dSipB 120615.8%, dSipD
80614%; Figure S1B). Nevertheless, consistent with previous
observations [5,21], SipB localized to both the plasma membrane
and the bacterial surface, whereas SipD could only be weakly
detected on the surface of some (,10%) internalized bacteria
(Figure S1C). Therefore, the increased invasiveness of the dSipC
strain likely arises from SipC effector function rather than any
unrelated effect on effector translocation.
As S.typhimurium mutants lacking sptP and WT are equally
invasive [17], the observed rate increases associated with the
dSopE, dSopB and dSipC strains likely reflect the stimulatory
action of the augmented effector rather than decreased delivery of
the signal-suppressing effector SptP. Indeed, levels of delivered
SopE and SopB in WT, an sptP mutant and the dSptP strain are
indistinguishable (D. Humphreys, unpublished). In addition,
SopE, SopB or SipC are each able to stimulate actin polymer-
ization in cultured cells, although alone are insufficient to trigger
bacterial entry [6,11]. Salmonella sopE or sopB deletion mutants
exhibit only a modest decrease in invasion, whereas sipC null
mutants are non-invasive, as SipC is not only an effector but also a
translocator of other effectors [4,16,22]. These combined data
therefore strongly support linkage between the delivered dose of
stimulatory effectors, the resulting extent of actin polymerization
and Salmonella invasion rate.
However, when cultured cells were transfected with effectors
(denoted ‘t-effector’) and infected with WT S.typhimurium
(Figure 1C, left), only mild rate increases (,120% i.e. an
approximately 0.2-fold increase when compared to WT normal-
ized to 100%) were evident. A comparable effect was observed
when control Cdc42-dependent actin polymerization and macro-
pinocytosis were induced with bradykinin (Figure 1C, right).
tSptP and tSipB conferred a limited resistance to invasion
(54637% and 56622%, respectively), consistent with their ability
to counteract cytoskeletal and nuclear responses and to disrupt
cellular endomembranes, respectively (Figure 1C, right; Figure
S1D; Figure S1E; [17,23]). Additionally, we verified that
transfectants remained viable and that effectors were expressed
and localized correctly (Figure S2A). Indeed, the concentration of
each t-effector in the plasma membrane exceeded that of the
corresponding d-effectors in infected cells (Figure S2B). Thus,
although tSopE, tSopB and tSipC all trigger dramatic cytoskeletal
reorganization [19], unlike delivered effectors (Figure 1B, right),
these transfected effectors are unable to significantly influence
invasion rate, either because the effectors distribute along the
plasma membrane throughout the cell, rather than at specific
pathogen contact sites as with the T3SS-delivered effectors, or
because their premature activity inhibits WT entry. Together
these data reveal that the spatio-temporal context of effector
activity seems critical, as only cytoskeletal rearrangements induced
by delivered stimulatory effectors can significantly increase
bacterial invasion rate.
SipC stimulates invasion independently of cellular Rho-
family GTPases
To determine whether the enhanced invasion rates of the
dSopE, dSopB and dSipC strains reflect specific effector-induced
stimulation of defined cellular signaling pathways, we next
investigated the consequence of transfecting cells with dominant
negative Rho-family GTPases prior to infection with WT
Salmonella or each of the effector-augmented strains (Figure 2A).
As expected, tCdc42(N17), tRac1(N17) and tRhoA(N19) expres-
sion suppressed WT S.typhimurium invasion by ,40%, confirming
Rho-family GTPases as important cellular targets of delivered
Salmonella effectors (Figure 2B; [14,24]). When tCdc42(N17) or
tRac1(N17) transfectants were infected with the dSopE or dSopB
strains, the previously observed increases in invasion rate
significantly diminished (e.g. tCdc42(N17):dSopE –163%;
tRac1(N17) 2238%), yet remained unaltered by tRhoA(N19)
expression. Conversely, none of the expressed dominant negatives
suppressed the enhanced invasion rate of the dSipC strain (e.g.
tCdc42(N17) +19%; tRhoA(N19) +13%), indicating that SipC
activity is Rho-family GTPase independent (Figure 2B). Fur-
thermore, unlike the WT, the invasion rate of the dSipC strain was
equivalent in each dominant negative background (i.e. in
Figure 2B, compare constant dSipC invasion rate to decreases
in WT rate in the dominant negative backgrounds), suggesting
that augmenting SipC delivery can compensate for the reduction
in SopE/SopB-dependent stimulation of Cdc42/Rac1-dependent
signaling. This is consistent with the ability of SipC to induce
actin reorganization directly [7]. These data illustrate that
three entry effectors cooperate in the WT strain to stimulate
parallel Cdc42/Rac1-dependent (SopE, SopB) and –independent
(SipC) invasion pathways, the relative contribution of which
can be modulated by the comparative levels of each effector
delivered.
Author Summary
Critical to the onset of Salmonella infection is the ability of
bacteria to force their own entry (‘invade’) into intestinal
cells of their mammalian host from where they replicate,
spread and cause damage. To achieve this invasion,
Salmonella deliver a cocktail of proteins directly into host
target cells. These proteins override host cell communica-
tions and remodel cell structure, tricking the normally
dormant cells into engulfing the invaders. Although we are
beginning to understand the functions of each delivered
protein, little is known about how their activities are
coordinated. Here we describe new techniques that
systematically examine the interplay between the deliv-
ered bacterial proteins within the host cell. The results
illuminate an unexpectedly complex network of interrelat-
ed relationships that must be precisely coordinated to
promote bacterial invasion. The data provide new insights
into how this important pathogen triggers invasion of host
cells during infection.
Salmonella Entry Effector Interplay
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Figure 1. Only T3SS-delivered effectors influence bacterial invasion rate. A. Salmonella effectors that subvert host cytoskeletal dynamics.
Effectors are delivered into the host cell via the type III secretion system (T3SS). Effector delivery requires Salmonella invasion proteins SipB and SipC,
which form a plasma membrane-integral translocon likely linked to the T3SS by SipD. Two delivered effector Sips are actin-binding proteins (ABPs)
that modulate actin dynamics: SipC nucleates actin polymerization and cross-links (bundles) actin filaments (F-actin) at the cell plasma membrane
(pm), activities stimulated by SipA, which independently binds F-actin and inhibits filament depolymerization. Three further effectors are delivered
into the cell via a SipB-SipC-dependent mechanism: the GDP-GTP exchange factor (GEF) SopE (or ubiquitous SopE2) activates Cdc42 and Rac1 Rho-
family GTPases; the inositol polyphosphatase (IPase) SopB indirectly activates these GTPases and RhoG via inositol phosphate (PIP) hydrolysis; the
antagonistic GTPase activating activity (GAP) and tyrosine phosphatase activities of SptP inactivate signaling after bacterial entry. B. Left: Schematic
illustrating infection of cultured cells by wild-type or effector-augmented S.typhimurium strains. Wild-type bacteria endogenously express, secrete
and deliver sipA, sipC, sopE, sopB and sptP (abbreviated to acebp). Effector-augmented strains each express, secrete and deliver mildly increased levels
of an individual plasmid-encoded effector in the wild-type background [enhanced effector shown in capitals, e.g. aceBp (dSopB) and aCebp (dSipC)
produce increased levels of SopB and SipC, respectively]. Right: Graph comparing relative cell invasion rates of wild-type and effector-augmented
(denoted d-effector) S.typhimurium strains. Invasion was compared to wild-type after 60 min (assigned as 100%). Results are mean6SEM of 4
independent experiments each performed in triplicate. C. Left: Schematic illustrating infection of effector-transfected cells by S.typhimurium. Wild-
type bacteria endogenously express, secrete and deliver sipA, sipC, sopE, sopB and sptP (abbreviated to acebp). Cultured cells were transfected with
individual effectors prior to infection (denoted t-effector). Right: Graph comparing invasion of mock transfected (control), effector-transfected (t-
effector) or bradykinin-treated cells by wild-type S.typhimurium. Invasion was compared to wild-type after 60 min (assigned as 100%). Results are
mean6SEM of 4 independent experiments each performed in triplicate.
doi:10.1371/journal.ppat.1000037.g001
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Ordered effector interplay revealed by trans BENEFIT
screening
Based on this transfection-infection approach, we next designed
binary entry effector interplay (BENEFIT) screens to assess
potential cross talk between pairs of effectors. In the first ‘trans’
BENEFIT screen, we investigated the effects of expressing
individual bacterial effectors rather than dominant negative
derivatives of host proteins in cells prior to infection with WT
Salmonella or the effector-augmented strains (Figure 3A). We
conservatively defined functional interplay between effector A (‘d-
effector’; augmented levels of which are delivered via the T3SS in a
WT background) and effector B (‘t-effector’ pre-expressed in the
target cell by transient transfection) to be an increase (or decrease)
in rate of at least one-fold of WT after correction for WT Salmonella
invasion of cells expressing effector B (Figure 1C, right), and
invasion of control cells by WT Salmonella expressing augmented
levels of effector A (Figure 1B, right). This threshold is
significantly different from the controls (Mann Whitney U
p,0.05).
The results of this screen were striking, revealing reproducible
changes in Salmonella invasion rates (Figure 3B; Figure S3). Our
criteria identified four synergistic relationships. Two effector
combinations induced mild increases in invasion rates (dSopE:t-
SipC +128%; dSopB:tSopE +150%), whereas two further pairings
stimulated even more prominent changes (dSipC:tSipA +369%;
dSopB:tSipC +398% i.e. the invasion rate was ,4-fold greater
than WT entry into control cells). Direct observation of infected
cells in parallel revealed dramatic actin reorganization induced by
these pairings (Figure S4), the morphology of which often
reflected a combination of their reported activities [8,14,19].
These rate and phenotypic variations were not a simple function of
augmenting effector dose, as no significant effects were observed
using homotypic effector combinations under identical conditions
(i.e. dSopE:tSopE +8%; dSipC:tSipC +22%; Figure 3B and
Figure S2C). Furthermore, all these effects were apparently also
dependent on ordered effector activity, as inverse pairing resulted
in inhibition of bacterial invasion (e.g. dSipC:tSopE 276%;
dSipA:tSipC –120%). An extended screen including the dSipB
and dSipD strains confirmed that unlike SipC, which is involved in
both effector delivery and actin reorganization [4,7,22], SipB and
SipD neither functionally contribute to invasion nor engage in
synergy with any delivered effectors (Figure S3A; Figure S3B).
Significant inhibitory effects were also evident (Figure 3B).
Premature expression of either SopB or SptP in cells suppressed
subsequent infection by several Salmonella strains, in particular
dSopE (tSopB, 2196%; tSptP, 2159%), dSopB (2127%,
2105%) or dSipC (2213%, 2123%), and as with effector
synergy, this functional antagonism was reversed (e.g. tSipC:dSopB
+398%; tSopE:dSopB +150%) or annulled (e.g. tSipC:dSptP
211%; tSopE:dSptP +16%) using inverse pairings. Notably,
although both tSptP and tSipB impede WT invasion (tSptP
54637%; tSipB 56622%), the effector-augmented strains were
not significantly inhibited by tSipB expression (Figure S3B). The
inhibitory effects reflect true variations in invasion rate rather than
indiscriminate changes due to differential effector-induced cellular
toxicity, as effector transfection generated no significant alteration
in the number or viability of target cells (Figure S2A), a
conclusion reinforced further by the direct observation of
internalized bacteria (Figure S4).
While trans BENEFIT screening permitted the sequence of
effector activity to be dictated experimentally, an associated
limitation is the imposed effector concentration imbalance, as the
effector levels in transfected cells exceed those delivered by the
bacteria. However, when effector concentrations were assessed
Figure 2. SipC-mediated invasion occurs independently of
cellular Rho GTPases. A. Schematic illustrating the infection of cells
expressing dominant negative Rho-family GTPases by wild-type or
effector-augmented S.typhimurium strains. Wild-type bacteria endoge-
nously express, secrete and deliver sipA, sipC, sopE, sopB and sptP
(abbreviated to acebp). Effector-augmented strains each express,
secrete and deliver mildly increased levels of an individual plasmid-
encoded effector in the wild-type background [enhanced effector
shown in capitals, e.g. aceBp (dSopB) and aCebp (dSipC) produce
increased levels of SopB and SipC, respectively]. Cultured cells were
transfected with dominant negative Rho-family GTPases [Cdc42(N17),
Rac1(N17), RhoA(N19)] prior to infection (denoted t-dominant negative
GTPase). B. Cultured fibroblasts were transfected with dominant
negative Rho-family GTPases [tCdc42(N17), tRac1(N17), tRhoA(N19)]
prior to infection with wild-type or effector-augmented (d-effector)
S.typhimurium strains. Invasion rates after 60 min were compared to
wild-type (assigned as 100%). Results are mean6SEM of 4 independent
experiments each performed in triplicate. Baselines ‘wild-type’ and
‘DinvG’ denote WT S.typhimurium SL1344 and S.typhimurium DinvG
(T3SS deficient) invasion in each transfectant background, respectively.
Table shows differences in invasion rates (%) after correction. Shading
denotes a significant decrease (red) or no significant change (grey) in
invasion rates (Mann Whitney U p,0.05).
doi:10.1371/journal.ppat.1000037.g002
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following infection and transfection by quantitative immunoblot-
ting, analysis revealed the difference between transfected and
delivered effector concentrations was less than one order of
magnitude (3–8 fold excess in transfectants; Figure S2B).
Fractionation of transfected cells following infection with the
effector-augmented strains also demonstrated that both the
transfected and delivered effectors remained co-localized in the
plasma membrane and cytoskeletal fractions, as when expressed or
delivered in isolation (Figure S2C; [19]). Coupled to the fact that
a ‘dominant negative’ phenotype is induced only by tSopB and
tSptP, these control data further suggest that disordered effector
activity rather than non-specific effector concentration or
mislocalization likely accounts for this antagonism. Thus, the trans
BENEFIT data suggest that extensive functional interplay does
occur between delivered Salmonella effectors.
Sip-Sop synergy revealed by cis BENEFIT screening
We next modified the BENEFIT screen to eliminate the
imposed ordered effector activity and the concentration bias
resulting from transfection. In this ‘cis’ screen, cultured cells
were infected with pairwise mixtures of effector-augmented
strains, in combination with each other or WT S.typhimurium
(Figure 4A).
At first, an identical multiplicity of infection to the trans screen
was used, except that each infection mixture comprised an equal
proportion of two distinct effector-augmented S.typhimurium strains.
An antibiotic marker was introduced into one strain to allow the
relative invasion efficiency of each to subsequently be calculated.
Since the selection conferred a marginal competitive disadvantage
during mixed infection when compared to the isogenic non-
resistant strain (,25%), each infection was performed in
duplicate, allowing the strain carrying the marker to be alternated.
The mean invasion efficiency of each strain could then be
calculated and controlled for the marker-induced variation
(Figure 4A). We initially confirmed that 50:50 mixtures of
isogenic input strains were recovered at an equivalent output ratio,
i.e. strains that differed only with respect to the resistance marker
did not compete with each other and were recovered with
equivalent frequency from the infected cells [Figure 4B; e.g.
mixed WT:WT invasion rate was 100% to which component
strains contribute equivalently (50%:50%)], and that the enhanced
invasion rates observed with the dSopE, dSopB and dSipC strains
(Figure 1B, right) were recapitulated during mixed infection
[Figure 4B; e.g. the invasion rate of a mixed dSopE:dSopE strain
input remains ,3-fold WT (304%) to which component strains
contribute equivalently (152%:152%)].
Having experimentally verified these important assumptions, we
next performed a complete cis BENEFIT screen using heterolo-
gous mixtures of effector-augmented WT strains. As previously, we
conservatively defined functional interplay between effector A (‘d-
effector’) and effector B (‘d-effector’; delivered by a separate strain) to
be reflected by an increase (or decrease) in invasion rate of at least
one-fold of WT from the change recorded when WT Salmonella
expressing augmented levels of either effector A or B enter cells
independently (Figure 1B, right). Such changes are statistically
Figure 3. Ordered effector interplay revealed by trans BENEFIT
screening. A. Schematic illustrating trans BENEFIT screening (the
infection of cells expressing individual entry effectors by wild-type or
effector-augmented S.typhimurium strains). Wild-type bacteria endog-
enously express, secrete and deliver sipA, sipC, sopE, sopB and sptP
(abbreviated to acebp). Effector-augmented strains each express,
secrete and deliver mildly increased levels of an individual plasmid-
encoded effector in the wild-type background [enhanced effector
shown in capitals, e.g. aceBp (dSopB) and aCebp (dSipC) produce
increased levels of SopB and SipC, respectively]. Cultured cells were
transfected with individual entry effectors (denoted t-effector) prior to
infection. B. Cultured fibroblasts were transfected (t) with individual
effectors prior to infection with wild-type or effector-augmented (d-
effector) S.typhimurium strains. Invasion rates after 60 min were
compared to wild-type (assigned as 100%). Results are mean6SEM of
4 independent experiments each performed in triplicate. Baselines
‘wild-type’ and ‘DinvG’ denote S.typhimurium SL1344 and S.typhimurium
DinvG (T3SS deficient) invasion in each transfectant background,
respectively. Table shows differences in invasion rates (%) after
correction. Shading denotes a significant increase (green), significant
decrease (red) or no significant change (grey) in invasion (Mann
Whitney U p,0.05).
doi:10.1371/journal.ppat.1000037.g003
Salmonella Entry Effector Interplay
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Figure 4. Sip-Sop synergy revealed by cis BENEFIT screening. A. Schematic illustrating cis BENEFIT screening. Pair-wise combinations of
effector-augmented (d-effector) S.typhimurium strains [enhanced effector shown in capitals, e.g. aceBp (dSopB) and aCebp (dSipC) produce increased
levels of SopB and SipC, respectively] were mixed 50:50 (overall MOI 50), where one strain additionally carries spectinomycin resistance (SpR). The
mixed inoculum is used to infect cultured cells, and a reciprocal infection performed in parallel in which the opposing strain is spectinomycin
resistant. After infection (60 min), extracellular bacteria are killed with gentamicin and infected cell lysate dilutions replica plated on LB agar (depicted
white) and LB containing spectinomycin (grey). Overall invasion rate and invasion of the spectinomycin resistant strain are calculated by scoring
colony-forming units. The invasion rate of the strain lacking the marker is calculated by subtracting invasion of the spectinomycin resistant strain
from the overall value (X1, Y2). To correct for the mild influence of spectinomycin on invasion efficiency, invasion rates of individual strains are
averaged with the parallel experiment i.e. [X1+X2Sp]42 =X and [Y1+Y2Sp]42= Y. Each pair of infections were performed 4 times in triplicate. B.
S.typhimurium SL1344 or effector-augmented (d-effector) strains were mixed pair wise (50:50; MOI 50) for infection. Invasion of each strain was
assessed using selectable markers after 60 min (Figure 4A). Results are the mean of four independent experiments each performed in triplicate
Upper: Pie charts depict total invasion by each combination (size; combined %) and relative contribution of each strain (division; %). Lower: Tables
show difference (%) in total invasion rate (left) and relative invasion rate of each strain (right) after correction. Shading denotes a significant increase
(green) or no significant change (grey) in invasion rate (Mann Whitney U p,0.05).
doi:10.1371/journal.ppat.1000037.g004
Salmonella Entry Effector Interplay
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significantly different from the controls (Mann Whitney U
p,0.05).
As might be expected, the resulting variations in invasion rate
were lower in magnitude than in the trans BENEFIT screen, again
illustrating that effector concentration is related to invasion rate,
provided that host targets (e.g. actin, Rho GTPases, phosphoino-
sitides) remain in excess. Two significant synergistic relationships
were immediately evident (Figure 4B, dSipA:dSipC, +227%;
dSipC:dSopB, +169%) that independently corroborated the most
significant data from the trans BENEFIT screen (Figure 3;
Figure S3), and an additional potential synergy also emerged,
albeit nearer to the significance threshold (Figure 4B, dSipA:d-
SopB, +129%). Distinct synergistic classes could also be defined;
‘mutual’ where both strains benefit from their association [e.g. both
the dSipC (+74%) and the dSipA (+153%) strains gain from a
mixed dSipC:dSipA infection], or ‘selfish’ in which one strain
exploits its partner [e.g. only the dSipA strain (+144%) benefits
from a mixed dSipA:dSopB infection, whereas invasion of the
dSopB strain is unchanged or marginally compromised (216%)].
In contrast to the trans BENEFIT screen, no significant
antagonistic effects were observed (Figure 4B). This is consistent
with the view that inhibition arises from transfecting the cells with
effectors prior to invasion that subsequently interfere with the
ordered activities of bacterially-delivered effectors.
Co-infection with the effector-augmented strains never en-
hanced WT S.typhimurium invasion. Indeed, when mixed with the
dSopE or dSipA strains the WT was appreciably but not
significantly disadvantaged, as in mixed WT:dSipA and
WT:dSopE infections, the WT invasion rate was reduced from
the expected 50% to 11% and 26%, respectively (Figure 4B).
Enhanced expression of SipC also conferred a mild selective
advantage over the WT, as invasion of the dSipC strain increased
from the expected 112% to 160% when co-infected with WT
(Figure 4B). These data illustrate that one strain does not simply
passively assist the invasion of any partner. Rather, the increased
invasion conferred on any particular strain relates to the
concentration and activity of the effectors within the target cell
delivered by the strain itself or its co-infecting partner. To confirm
this further, we performed additional assays in which the initial
infection mixtures were artificially biased (90:10/10:90) to favour
one or other of the strains. Under these conditions, the previously
observed synergy was abolished as the recovered output
reproducibly mirrored the composition of the input mixture
(Figure S5). A threshold level of both delivered effectors is
therefore necessary to drive the observed synergy.
SipC-SopB synergy is driven by SipC-dependent
clustering of plasma membrane phosphatidylinositol-4,5-
bisphosphate
Our BENEFIT screening suggested that unexpectedly sophis-
ticated interplay occurs between multiple delivered Salmonella entry
effectors. Next, we further investigated one of the previously
unrecognized relationships using complementary genetic, bio-
chemical and cell biology techniques. We selected SipC-SopB
synergy for further analysis, as this was apparently a dominant
association identified by both the trans and cis BENEFIT screens.
Initially, we wished to establish whether known SipC and SopB
activities were required for synergy. The SipC N-terminal domain
(SipC-N; residues 1–120) directs actin filament bundling, whereas
the C-terminal domain (SipC-C; 200–409) induces actin nucle-
ation [7]. Correspondingly, tSipC-N and tSipC-C both reorga-
nized actin when expressed in cultured cells (Figure 5A). tSipC-C
localized to the leading cell edge where it induced lamellipodial
and filopodial protrusions reminiscent of those generated by
membrane-integral SipC [8,19], yet was distributed between the
cytoskeletal, cytosolic and plasma membrane fractions upon
mechanical fractionation (Figure 5A, SipC-C). tSipC-N local-
ized along induced hyper-elongated filopodia 30–60 mm in length,
an activity similar to the cellular actin-bundling protein fascin
[25], and predominantly to the plasma membrane fraction upon
mechanical fractionation (Figure 5A, SipC-N). However, when
cells expressing SipC-N or SipC-C were infected with effector-
augmented S.typhimurium strains, SipC-SopB synergy was attenu-
ated (Figure 5B). Indeed, unlike tSipC, tSipC-N significantly
inhibited invasion by the dSopE, dSopB and dSipC strains
(Figure 5B, i.e. compare dSopE:tSipC-N, 2248%; dSopB:tSipC-
N, 2168%; dSipC:tSipC-N, 2236% to dSopE:tSipC, +128%,
dSopB:tSipC, +398%, dSipC:tSipC, +22%), as premature actin
bundling is likely to intrinsically impede cytoskeletal plasticity
required for bacterial invasion. tSipC-C also inhibited dSopE and
dSipC invasion (Figure 5B, dSopE:tSipC-C, 2273%; dSipC;t-
SipC-C, 2129%), but could still apparently engage in limited
synergy with the dSopB strain, albeit below our imposed
significance threshold (dSopB:tSipC-C, +85%). These data suggest
a potential link to C-terminal domain function, but additionally
imply that plasma membrane localization of this region is
important for efficient synergy with SopB, reaffirming the view
that the plasma membrane is a critical interface for effector
interplay [19].
Next, we investigated whether SopB inositol phosphatase
activity was required for SipC-SopB synergy by examining the
effects of expressing the homologous invasion-associated inositol
phosphatase Shigella flexneri IpgD [26] or a phosphatase-dead SopB
derivative containing a C462S mutation in the active site
[SopBC462S; [20]] prior to infection with the bank of effector-
augmented S.typhimurium strains (Figure 6A). When pre-expressed
in cells, tSopB is a ‘dominant-negative’ inhibitor of the dSipA,
dSipC, dSopE and dSopB strains (Figure 3B; Figure 6B). This
effect was recapitulated using tIpgD (dSipA:tIpgD, 253%;
dSipC:tIpgD, 2106%; dSopE:tIpgD, 2231%; dSopB:tIpgD,
276%), although inhibition of the dSipA and dSopB strains was
somewhat reduced. Nevertheless, this functional substitution
suggested that inhibition is driven by inositol phosphatase activity
rather than an unknown SopB-specific function. In clear support
of this, significant inhibition was alleviated using phosphatase-dead
tSopBC462S (Figure 6B; dSipA:tSopBC462S, 211%; dSopE:t-
SopBC462S, 295%; dSopB:tSopBC462S, 242%; dSptP:tSopBC462S,
28%), and invasion of the dSipC strain specifically but mildly
enhanced (dSipC:tSopBC462S, +97%).
To investigate the effect of SopB inositol phosphatase activity on
SipC synergy during infection, we generated a S.typhimurium strain
engineered to deliver increased levels of SopBC462S in the WT
background (dSopBC462S), and included this in a trans BENEFIT
screen where effector-transfected cells were infected with dSopE,
dSopB or dSopBC462S strains (Figure 7A). Synergy between tSipC
and dSopBC462S was markedly attenuated to near the statistical
threshold (Figure 7B, compare tSipC:dSopB, +298% to tSipC:d-
SopBC462S, +111%), whereas the weaker tSopE synergy was
abolished (Figure 7B, compare tSopE:dSopB, +150% to
tSopE:dSopBC462S, +19%). The latter is a recognized relationship
mediated by cellular inositol phosphates [16]. Additionally, unlike
the dSopB strain, dSopBC462S invasion was not inhibited in cells
expressing SipA, SopB or SptP (e.g. compare tSptP:dSopB,
2105% to tSptP:dSopBC462S, 225%). These combined findings
suggested that SopB inositol phosphatase activity contributes to
synergy with membrane localized SipC.
SopB additionally aids invasion by cleaving plasma membrane
phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2] to promote
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membrane elasticity and vacuole formation [20]. To establish
whether levels of PI(4,5)P2 influence invasion the augmented
dSopB strain, we expressed phosphatidylinositol-4-phosphate-5-
kinase [PIP(5)K], which catalyzes the formation of PI(4,5)P2, in
cells prior to infection with the effector augmented S.typhimurium
strains. Strikingly, excess PI(4,5)P2 stimulated WT Salmonella
invasion more than two-fold (Figure 8A), and specifically and
significantly enhanced dSopB strain invasion (Figure 8A;
tPIP(5)K:dSopB, +608%), while inhibiting the dSopE strain
(Figure 8A; tPIP(5)K:dSopE, 2320%). The phenotypic similarity
between tPIP(5)K:dSopB and tSipC:dSopB suggested that SipC
might generate PI(4,5)P2 either directly or via PIP(5)K stimulation.
Indeed, the periphery of Salmonella-induced membrane ruffles are
enriched for PI(4,5)P2 [20].
To pursue this hypothesis, we assessed the relative proportion of
phosphatidylinositol species in cells expressing Salmonella effectors
by radioactive counting of fractions separated by ion exchange
chromatography (Figure 8B). When compared to resting cells,
tSopB lysates contained significantly enhanced levels of phospha-
tidylinositol-3,4,5-trisphosphate [PI(3,4,5)P3] and phosphatidyli-
nositol-3,4-bisphosphate [PI(3,4)P2], likely to be a stable break-
down product of PI(3,4,5)P3 [27], and to a lesser extent
phosphatidylinositol-3-phosphate [PI(3)P] (Figure 8B, tSopB).
By comparison, no major alterations were observed when
comparable tSipC or tSptP lysates were assayed (Figure 8B,
tSipC and tSptP). These biochemical data demonstrate that
SipC itself does not directly or indirectly generate PI(4,5)P2, but do
not preclude that SipC alters the local concentration or
distribution of existing PI(4,5)P2 in the membrane. To examine
this possibility, the PI(4,5)P2-binding plextrin-homology (PH)
domain of phospholipase Cd fused to green fluorescent protein
(PLCd-PH-GFP) was expressed in cultured cells prior to infection
with effector-augmented strains to report PI(4,5)P2 distribution
during invasion [20]. As expected, the membrane ruffles
associated with actin rearrangements induced by the dSopB strain
were largely devoid of PI(4,5)P2, indicated by the diffuse reporter
probe distribution (Figure 8C, dSopB PLCd-PH-GFP). In
contrast, membrane ruffles generated by the dSipC strain were
enriched with PLCd-PH-GFP, which was frequently coincident
with induced actin rearrangements and concentrated at filopodial
tips (Figure 8C, dSipC). Clusters of PLCd-PH-GFP were also
clearly evident at the plasma membrane, a distribution strikingly
similar to that of SipC itself [8,19]. Although cells infected with the
dSopE strain also induced profuse membrane ruffles morpholog-
ically more reminiscent of the dSipC strain [19], no PI(4,5)P2
enrichment or clustering was evident (Figure 8C, dSopE). These
Figure 5. Membrane localization of the C-terminal SipC actin-
nucleation domain is required for synergy with SopB. A.
Localization of SipC derivatives expressed in cultured cells. Upper:
Immunofluorescence micrographs of fixed NIH3T3 cells transiently
expressing SipC-C or SipC-N. Left column shows merged double
immunofluorescence (merge) of cells stained 48 h after transfection
with anti-FLAG IgG/AlexaFluor 488-conjugated anti-mouse IgG to
localise SipC derivatives (green) and Texas Red-conjugated phalloidin
to visualize F-actin (red). Effector channel alone is shown in greyscale
for clarity (effector). Images are representative of .100 cells from three
independent experiments. Scale bars, 2 mm. Lower: Cultured NIH3T3
cells were transiently transfected with expression vectors encoding
SipC-C or SipC-N. After 48 h transfectants were mechanically fraction-
ated, and each subfraction [nuclei (N), internal membranes/cytoskele-
ton (IM/CS), cytoplasm (C), plasma membrane (PM)] analyzed by
immunoblotting with anti-SipC polyclonal antibody. B. Cultured
fibroblasts were transfected (t) with SipC or derivatives SipC-N or
SipC-C prior to infection with wild-type or effector-augmented (d-
effector) S.typhimurium strains. Invasion rates after 60 min were
compared to wild-type (assigned as 100%). Results are mean6SEM of
4 independent experiments each performed in triplicate. Baselines
‘wild-type’ and ‘DinvG’ denote S.typhimurium SL1344 and S.typhimurium
DinvG (T3SS deficient) invasion in each transfectant background,
respectively. Table shows differences in invasion rates (%) after
correction. Shading denotes a significant increase (green), significant
decrease (red) or no significant change (grey) in invasion (Mann
Whitney U p,0.05).
doi:10.1371/journal.ppat.1000037.g005
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data suggest that localized accumulation or clustering of plasma
membrane PI(4,5)P2 by SipC enhances the availability of SopB
substrate at bacterial entry foci. These findings from biochemical
and cell biology approaches demonstrate the physiological context
of a novel relationship highlighted by our genetic BENEFIT
screening and extend our mechanistic understanding of SipC-
SopB interplay.
Discussion
Emerging evidence has inferred that multiple effectors delivered
by bacterial T3SSs act cooperatively within the target cell to
subvert host signaling processes [8,17,28]. Salmonella invasion of
host cells is a paradigm system in which the biochemical activities
of the central T3SS effectors that manipulate cellular actin
dynamics are likely identified [6,11]. However, the nature and
extent of cross talk between these effectors that co-localize at the
target cell plasma membrane remained unknown [19]. Our
findings provide initial insights into a sophisticated program of
ordered effector activities underlying cell invasion by Salmonella
(Figure 9). The BENEFIT screening data identify extensive novel
Sip-Sop synergy (SipC-SopB; SopB-SipA; SipC-SopE), and
additionally validate every cooperative [SipA-SipC [8]; SopB-
SopE [16]] and antagonistic [SopE-SptP [17]] effector relation-
ship detected by previous genetic or biochemical approaches.
We demonstrate that SipC promotes actin polymerization
independently of Rho-family GTPases. This is clearly consistent
with the ability of SipC to nucleate actin polymerization directly
[7], and support a fundamental role for this function during
invasion [22,29]. SipC also emerges as a central participant in a
more extensive signaling network, as it engages in potent
synergistic relationships with delivered SipA and SopB, and to a
lesser extent with SopE. Such early intracellular communication
between SipC and Sops reconciles the observation that triple
Salmonella mutants lacking sopE, sopE2 and sopB are unable to
efficiently induce actin rearrangements [16]. Network architecture
implies that SipC not only cooperates with SipA to directly trigger
actin reorganization [8], but also concurrently reinforces signaling
by indirectly stimulating SopB and SopE activity. This ‘feed-
forward’ amplification and evolved effector interdependency may
allow the Cdc42/Rac1-dependent pathway to dominate during
WT infection [24].
Our data reveal an important role for phosphoinositides in
mediating the dominant and previously unrecognized synergy
between SipC and SopB. PI(4,5)P2 clusters in membrane ruffles
generated specifically by SipC, and is subsequently hydrolysed by
SopB. As only the dSopB strain gains from co-infection with the
dSipC strain, this suggests that prior PI(4,5)P2 concentration at
entry sites either by dSipC or experimentally with tSipC
subsequently enhances the invasion of the dSopB strain, which is
more adept at ruffle closure by virtue of augmented inositol
phosphatase activity. Like SipC, we show that PI(4,5)P2 concen-
trates locally at the tip of induced filopodia [19]. This is consistent
with co-secreted cholesterol-binding SipB initially integrating into
cholesterol-rich regions of the plasma membrane [5], where
PI(4,5)P2 also concentrates. It is also tempting to speculate that
Figure 6. SopB inositol phosphatase activity is required for
inhibition of Salmonella entry. A. Schematic illustrating the infection
of cells expressing SopB, catalytically inactive SopBC462S or the Shigella
inositol phosphatase IpgD with wild-type or effector-augmented
S.typhimurium strains. Wild-type bacteria endogenously express, secrete
and deliver sipA, sipC, sopE, sopB and sptP (abbreviated to acebp).
Effector-augmented strains each express, secrete and deliver mildly
increased levels of an individual plasmid-encoded effector in the WT
background [enhanced effector shown in capitals, e.g. aceBp (dSopB)
and aCebp (dSipC) produce increased levels of SopB and SipC,
respectively]. Cultured cells were transfected with individual entry
effectors or effector derivatives (denoted t-effector) prior to infection. B.
Cultured fibroblasts were transfected (t) with SopB, a catalytically
inactive SopBC462S derivative, or the Shigella inositol phosphatase IpgD
prior to infection with wild-type or effector-augmented (d-effector)
S.typhimurium strains. Invasion rates after 60 min were compared to
wild-type (assigned as 100%). Results are mean6SEM of 4 independent
experiments each performed in triplicate. Baselines ‘wild-type’ and
‘DinvG’ denote S.typhimurium SL1344 and S.typhimurium invG (T3SS
deficient) invasion in each transfectant background, respectively. Table
shows differences in invasion rates (%) after correction. Shading
denotes a significant increase (green), significant decrease (red) or no
significant change (grey) in invasion (Mann Whitney U p,0.05).
doi:10.1371/journal.ppat.1000037.g006
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PI(4,5)P2 might also influence bacterial SipC actin nucleation
activity, as this species is a stimulatory co-factor of cellular Arp2/3-
dependent actin polymerization [30,31]. Similarly, our findings
that tSopB generates PI(3,4,5)P3, PI(3,4)P2 and PI(3)P concurs
with reports of SopB-dependent stimulation of RhoG via SGEF
and PI(3)P accumulation on Salmonella-containing vacuoles
[12,32].
BENEFIT screening not only defines such previously undetect-
ed relationships between delivered effectors, but also supports the
view that a controlled programme of temporal effector activities
drives Salmonella invasion. In the trans screen, the detected synergies
are unidirectional, i.e. tSipC enhances invasion of the dSopB strain
but not vice versa, an effect recapitulated in the cis screen, when co-
infecting strains synergise selfishly or mutually. Also, tSopB or
tSptP expression in cells prior to infection selectively inhibits
invasion of particular augmented strains. This experimentally
imposed asynchronous SopB or SptP activity likely inhibits
subsequently delivered effectors by sequestering or down-regulat-
ing essential cellular targets (Rho family GTPases) or by
prematurely inter-converting necessary secondary messengers
through SopB inositol phosphatase activity or SptP-dependent
protein dephosphorylation. As tSptP also reduces WT invasion,
this might reflect a premature generalized GAP-driven protective
effect [17]. However, tSopB only inhibits the invasion of certain
effector-augmented strains (i.e. not the WT) indicative of specific
functional interplay, a phenotype abolished when tSopB deriva-
tives are expressed that lack inositol phosphatase activity. The
BENEFIT screens do not distinguish whether these temporal
relationships reflect the ordered activity of simultaneously
delivered effectors or a requirement for sequential effector delivery
via the T3SS. The available experimental data from WT infection
still remain consistent with either scenario: delivered effectors co-
localize at the plasma membrane [19]; ‘early’ acting SopE and
‘late’ SptP are present in cells at equimolar concentrations after
15 minutes [33]; and imaging of effector delivery suggested
equivalent kinetics for both SipA and SopE transfer [34]. What
is clear from our data is that the T3SS has evolved to ensure that
delivered effectors are precisely dosed in the WT to balance
efficient bacterial invasion and host cell viability.
Although most effector relationships are common to both
BENEFIT screens, SipA-SopB synergy that favoured the dSopB
strain emerged uniquely from the cis screen. Why this phenotype
was constrained to mixed infection is as yet unclear, although it
might relate to the recently identified role of these effectors in
invasion-associated tight junction disruption [35]. Provocatively,
both these effectors also have additional intracellular roles in
controlling the subsequent maturation and positioning of Salmonella
containing vacuoles [32,36], although whether these functions are
simultaneously activated 60 minutes after infection remains
unknown.
Our data provide the first systematic experimental study
examining the scope, nature and relative potency of interplay
between bacterial effectors delivered into eukaryotic cells.
Nevertheless, as with any experimental system BENEFIT screens
inevitably also have associated limitations. These include the use of
a cultured cell model and genetically modified Salmonella strains,
and the possibility that changes in invasion rate used as a readout
result from temporal alterations or asynchrony in the process or
differential effector stability rather than interplay. These aspects
are technically challenging to monitor and control. However,
coupled to the fact that our screening detected every previously
identified effector association, our extended investigation of the
novel SipC-SopB synergy using complementary biochemical and
cell biology approaches, provides strong supporting evidence that
Figure 7. SopB inositol phosphatase activity is required for
synergy with SipC during Salmonella entry. A. Schematic
illustrating trans BENEFIT screening to investigate the role of SopB
inositol phosphatase activity. Wild-type bacteria endogenously express,
secrete and deliver sipA, sipC, sopE, sopB and sptP (abbreviated to
acebp). Effector-augmented strains each express, secrete and deliver
mildly increased levels of an individual plasmid-encoded effector in the
wild-type background [enhanced effector shown in capitals, e.g. in this
assay aceBp (dSopB), aceBC462Sp (dSopBC462S) and acEbp (dSopE) that
produce increased levels of SopB, catalytically inactive SopBC462S or
SopE, respectively]. Cultured cells were transfected with individual entry
effectors (denoted t-effector) prior to infection. B. Cultured fibroblasts
were transfected (t) with individual effectors prior to infection with
wild-type or effector-augmented (d-effector) S.typhimurium strains. In
this assay dSopE, dSopB and dSopBC462S strains were examined.
Invasion rates after 60 min were compared to wild-type (assigned as
100%). Results are typical of those obtained in two independent
experiments each performed in triplicate. Baselines ‘wild-type’ and
‘DinvG’ denote S.typhimurium SL1344 and S.typhimurium DinvG (T3SS
deficient) invasion in each transfectant background, respectively. Table
shows differences in invasion rates (%) after correction. Shading
denotes a significant increase (green), significant decrease (red) or no
significant change (grey) in invasion (Mann Whitney U p,0.05).
doi:10.1371/journal.ppat.1000037.g007
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Figure 8. SipC-dependent relocalization of phosphatidylinositol-4,5-bisphosphate (PI45P2) drives synergy with SopB. A. Fibroblasts
were transfected with cellular phosphatidylinositol-4-phosphate-5-kinase (tPIP(5)K) prior to infection with wild-type or effector-augmented (d-
effector) S.typhimurium strains. Invasion rates after 60 min were compared to wild-type (assigned as 100%). Results are mean6SEM of 4 independent
experiments each performed in triplicate. Baselines ‘wild-type’ and ‘DinvG’ denote S.typhimurium SL1344 and S.typhimurium DinvG (T3SS deficient)
invasion in each transfectant background, respectively. Table shows differences in invasion rates (%) after correction. Shading denotes a significant
increase (green), significant decrease (red) or no significant change (grey) in invasion (Mann Whitney U p,0.05). B. Graph showing relative change
(compared to mock transfected control cells) in concentration of specific phosphatidylinositol species [PI(3,4,5)P3, phosphatidylinositol-3,4,5-
trisphosphate; PI(4,5)P2, phosphatidylinositol-4,5-bisphosphate; PI(3,4)P2, phosphatidylinositol-3,4-bisphosphate; PI(3,5)P2, phosphatidylinositol-3,5-
bisphosphate; PI(5)P, phosphatidylinositol-5-phosphate; PI(4)P, phosphatidylinositol-4-phosphate; PI(3)P, phosphatidylinositol-3-phosphate) in
transfectants expressing SptP, SopB and SipC following HPLC analysis of radiolabelled fibroblasts. Data shown are representative of those obtained
in two independent labelling experiments. C. Immunofluorescence micrographs of NIH3T3 cells expressing PLCd-PH-GFP fixed after infection
(60 min) with S.typhimurium strains engineered to express augmented levels of SopB, SopE or SipC. Left column shows merged triple
immunofluorescence (merge) of cells stained with Texas Red-conjugated phalloidin to visualize F-actin (red) and DAPI to visualize cell nuclei and
bacteria (blue, internalized bacteria indicated with arrows). GFP fluorescence was visualized directly. Actin (F-actin) and PLCd-PH-GFP channels are
also shown in greyscale for clarity. Images are representative of .100 cells from independent experiments. Scale bars, 2 mm.
doi:10.1371/journal.ppat.1000037.g008
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the previously unrecognized relationships emerging from our
screening reflect bona fide effects. Nevertheless, each of the
identified associations now requires further in depth investigation.
Biochemical and structural studies have illustrated that
many effectors comprise defined domains that act as functional
modules [37], for example SipA contains a C-terminal actin-
binding domain and an N-terminal region that influences
phagosome positioning [9,36]. As we have demonstrated
with our analysis of SipC-C and SipC-N function and the
catalytic-dead SopB derivative, BENEFIT screening assays can
now be exploited further to decipher the relative contribution of
such discrete functions to effector interplay, and to examine
how as yet undefined Salmonella effectors might contribute
to invasion. As demonstrated using Rho-family GTPases as
proof-of-principle, dominant negative and RNAi approaches can
also be employed to examine the involvement of additional host
targets in distinct effector-stimulated signaling pathways. The
assays could also be adapted to examine virulence proteins in other
pathogen-induced processes, provided that there is a readily
quantifiable output phenotype such as bacterial replication or
dissemination.
Materials and Methods
Bacterial strains and cell culture
Construction of S.typhimurium SL1344 strains engineered to
express augmented levels of individual entry effectors in a WT
background has been described in detail previously [19]. Briefly,
S.typhimurium SL1344 was transformed with expression
plasmids pB:SopEFLAG, pB:SopBFLAG, pB:SopBFLAG pB:SipA,
pB:SptPFLAG, pB:SipC, pB:SipB or pB:SipD generated by PCR
amplification of sopE, sopB, sipA, sptP, sipC, sipB or sipD engineered
to contain NdeI and HindIII sites from an SL1344 chromosomal
DNA template, into pTrc99A-FF4 to allow constitutive low-level
expression downstream of the Trc promoter [38,39].
pB:SopBC462SFLAG was generated identically, except the TGT
codon at nucleotide 1383 of sopB was mutated to TCC to
generate a cysteine to serine substitution at amino acid 462.
Immunoblotting and densitometry of cell lysates and secreted
proteins from each strain showed that plasmid-encoded SopE,
SopB, SipA, SptP or SipC expression was specifically but mildly
augmented (1.5–3.360.28 fold WT) due to the low copy number
plasmid in the absence of induction, and that this elevated
expression correlated with increased effector secretion (1.5–
2.060.28 fold WT). This also correlated with a mild increase in
concentrations of delivered effectors, as each could be detected by
immunofluorescence or immunoblotting of cell lysates after
infection with the engineered strains but were below the detection
threshold after WT infection under the same conditions [19].
Exogenous expression of plasmid-encoded effectors did not
interfere with the expression, secretion or delivery of other
chromosomal SPI1- or SPI2-secreted effectors [[19], and L.Brawn,
unpublished observations]. Expression and secretion of SipB and
SipD are documented in Figure S1. S.typhimurium SL1344 strains
were maintained on Luria-Bertani agar or cultured in tryptone
yeast medium (2TY) containing ampicillin or spectinomycin
(50 mgml21), as appropriate.
NIH3T3 fibroblasts were cultured in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% (v/v) fetal calf
serum (FCS), L-glutamine and penicillin/streptomycin (Sigma/
Invitrogen) (37uC, 5% CO2). When required cells were treated
with bradykinin (30 ngml21; 37uC, 5% CO2, 60 min). To assess
number and viability, ,16106 cells were scraped into PBS, ice
cold 70% (v/v) ethanol added (10vol), and the mixture incubated
(4uC, 30 min). Cells were then pelleted (900g, 5 min) and
resuspended in PBS. RNAse and propidium iodide were added,
and the mixture incubated (37uC, 30 min). Cell clumps were
dispersed by passage through a 25-gauge needle and samples
analysed for forward scatter, side scatter and fluorescence on a
FACScan flow cytometer (Becton Dickinson, USA), collecting
.20000 events per sample.
Eukaryotic expression vectors pT:SopEFLAG, pT:SopBFLAG and
pT:SptPFLAG containing sopE, sopB, and sptP were generated by
PCR amplification from the S.typhimurium SL1344 chromosome
and cloning of products, engineered to contain BamHI and XhoI
sites into pT:FLAG [19], a fusion of AlwNI-digested phrGFP-NUC
and pIRES-hrGFP (Stratagene). pT:SipA, pT:SipC and pT:SipB
were constructed by cloning of sipA, sipC or sipB PCR products
engineered to contain XbaI and HindIII sites into pcDNA3.1
(Invitrogen). pT:SipCNFLAG and pT:SipCCFLAG were generated
by PCR amplification of nucleotides 1–360 and 600–1230 of sipC
corresponding to amino acids 1–120 and 200–409 and cloning
into pT:FLAG. pT:IpgDFLAG was generated by PCR amplification
of ipgD from the Shigella flexneri M90T virulence plasmid and
cloning into pT:FLAG. pT:SopB
C462S
FLAG was generated as
described for pB:SopBC462SFLAG, except that the PCR product
was cloned into pT:FLAG. pPLCd-PH-GFP expressing the PH-
domain of phospholipase Cd that specifically binds phosphatidy-
linositol-4,5-bisphosphate [PI(4,5)P2] fused to C-terminal GFP was
a kind gift from Phill Hawkins (Babraham Institute, Cambridge).
pT:PIP(5)K was generated by PCR amplification of the cDNA
encoding murine phosphatidylinositol-4-phosphate-5-kinase and
cloning of the product into pcDNA3.1.
BENEFIT screens
The ‘cis’ or ‘trans’ binary entry effector interplay (BENEFIT)
screens are a modification of the gentamicin protection assay,
which measures the ability of Salmonella strains to invade cultured
cells [40].
Figure 9. Interplay between delivered Salmonella entry effec-
tors. Schematic summary of the synergistic (green arrows) and
antagonistic (red arrow) relationships between delivered Salmonella
invasion effectors revealed by BENEFIT screening. Arrow width depicts
relative magnitude of functional cooperativity. Abbreviations, ABP
(actin-binding protein), GEF (GTPase exchange factor), IPase (inositol
phosphatase), GAP (GTPase activating protein).
doi:10.1371/journal.ppat.1000037.g009
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‘trans’ BENEFIT screen
Stationary phase S.typhimurium SL1344 cultures transformed
with pB:sopEFLAG, pB:sopBFLAG, pB:sptPFLAG, pB:sipCFLAG,
pB:sipA, pB:sipB, pB:sipD or vector control [19], were diluted
1:500 in 2TY and incubated to maximise invasion efficiency (6 h,
37uC, 225 r.p.m.). Bacteria were washed and resuspended in
DMEM supplemented with L-glutamine, and added at a
multiplicity of infection (MOI) of 50 to 26104 serum-starved
NIH3T3 fibroblasts, transfected 48 h previously with expression
plasmids pT:sopEFLAG, pT:sopBFLAG, pT:sopB
C462S
FLAG,
pT:sptPFLAG, pT:sipCFLAG, pT:sipCNFLAG, pT:sipCCFLAG, pT:sipA,
pT:ipgDFLAG, pT:PIP(5)K or empty vector [19] using Lipofecta-
mineTM, according to the manufacturer’s instructions (Invitrogen).
Transfection efficiency, assessed by GFP-NLS co-expression or
immunofluorescence [19] was always .85%. After incubation
(37uC, 5% CO2, 60 min), cells were repeatedly washed with warm
PBS and extracellular bacteria killed with gentamicin (100 mgml21
in DMEM; 37uC, 5% CO2, 60 min). Cells were washed again
with PBS and lysed in 10 mM Tris-Cl, pH 7.4, 0.5% (v/v) triton
X-100. Serial lysate dilutions were plated onto LB agar and the
percentage of intracellular bacteria compared to the original
inoculum. Rates were referenced against invasion of WT
S.typhimurium SL1344 and an isogenic invasion deficient mutant
lacking invG, an essential structural component of the T3SS,
assigned as 100% and 0% respectively, in each transfectant
background. Functional interplay between effector A (‘deffector’;
delivered via the T3SS) and effector B (‘teffector’ pre-expressed in
the target cell by transient transfection) was defined as an increase
(or decrease) in rate of at least one-fold (i.e. 6100%) of WT after
correction for WT Salmonella invasion of cells expressing effector B
and invasion of control cells by WT Salmonella expressing
augmented levels of effector A.
‘cis’ BENEFIT screen
Stationary phase S.typhimurium SL1344 cultures transformed
with pB:sopEFLAG, pB:sopBFLAG, pB:sptPFLAG, pB:sipCFLAG,
pB:sipA or empty vector [19], were diluted 1:500 in 2TY and
incubated to maximise invasion efficiency (6 h, 37uC, 225 r.p.m.).
Bacteria were washed and resuspended in DMEM supplemented
with L-glutamine and mixed at a 50:50 or 90:10/10:90 ratio as
appropriate to give an MOI of 50, when 26104 serum-starved
NIH3T3 fibroblasts were infected. An antibiotic marker (specti-
nomycin) was introduced into one strain to allow the relative
invasion efficiency of each strain to subsequently be calculated.
Since selection conferred a marginal disadvantage (,5%), each
infection was performed in duplicate to allow the marker to be
alternated. After incubation (37uC, 5% CO2, 60 min), cells were
repeatedly washed with warm PBS and extracellular bacteria killed
with gentamicin (100 mgml21 in DMEM; 37uC, 5% CO2,
60 min). Cells were washed again with PBS and lysed in 10 mM
Tris-Cl pH 7.4, 0.5% (v/v) triton X-100. Serial dilutions were
plated onto LB agar with and without spectinomycin and the
percentage of intracellular bacteria compared to the original
inoculum. In the cis assay, functional interplay between effector A
(‘dA’; delivered via the T3SS) and effector B (‘dB’; delivered by
the T3SS of a separate strain) was defined as an increase (or
decrease) in rate of at least one-fold (i.e. 6100%) of WT after
correction for the rate expected when either strain invades cells
independently.
In both screens, the results presented are the mean6SEM of 4
independent experiments each performed in triplicate and the
changes reported statistically significant from the controls (Mann
Whitney U p,0.05).
Immunofluorescence microscopy
Infected or transfected cells were washed in PBS and fixed with
3.7% (v/v) paraformaldehyde for fluorescence microscopy. Fixed
samples were permeabilized with 0.2% (v/v) triton X-100 in PBS,
blocked with 3% (w/v) bovine serum albumin (BSA) in PBS (1 h,
RT), then incubated with appropriately diluted primary antibodies
(anti-FLAG monoclonal or anti-effector polyclonal) in PBS (1h,
RT). Samples were sequentially incubated with AlexaFluor 488-
conjugated anti-rabbit or anti-mouse IgG secondary antibodies,
according to manufacturer’s instructions (30 min, RT; Invitrogen),
then Texas Red-conjugated phalloidin (20 min, RT; Invitrogen)
and 49,69-diamidino-2-phenylindole dihydrochloride (DAPI, Sig-
ma) in PBS. Coverslips were mounted using ProLong Anti-fade
reagent (Invitrogen), and visualized using a fluorescence micro-
scope (Leica DM IRBE). Images were captured using a CCD
digital camera (Hamamatsu) and processed using OpenLab
software (Improvision). Where appropriate GFP fluorescence was
observed directly in fixed cells. Bacterial DAPI signal was
artificially enhanced to normalise the intensity to that of nuclear
staining.
Determination of effector concentration
Effector protein concentrations in transfected cells or delivered
into cells (measured 60 min after S.typhimurium infection) were
assayed by immunoblotting mechanical cell lysates or subcellular
fractions with antibodies raised against purified effectors [19].
Signal intensities were determined using NIH Image freeware
(http://rsb.info.nih.gov/nih-image/), and intensity values com-
pared to those derived by immunoblotting known concentrations
of purified effectors. Cells were fractionated as previously
described [19].
Quantitative analysis of inositol phospholipids in
cultured cells
Analysis was carried out as described [41]. Briefly, transfected
NIH3T3 cells were washed and incubated with phosphate-free
DMEM supplemented with 2% (v/v) dialysed heat-inactivated
FCS, 0.2% (w/v) fatty acid-free BSA and ,0.3 mCi [32P]Pi ml21
in 10 mM HEPES pH7.4 (diluted from an iso-osmotic stock) to
allow labelling of cellular phosphoinositides (37uC, 5% CO2,
75 min). Cells were rapidly aspirated and fixed with 1 vol ice-cold
1.0 M HCl, and scraped into glass vials containing 4 vol
CHCl3:MeOH (2:1, v/v), Folch carrier lipid and tetrabutylam-
monium sulphate (to give final ratio aqueous/MeOH/CHCl3
3:4:8). This was vortexed and centrifuged (1000g, 5 min) to
separate phases. The lower phase was removed into fresh tubes
containing synthetic upper phase, mixed and centrifuged (1000 g,
5 min), then dried in vacuo. Dried lipids were deacylated by
addition of monomethylamine reagent [41], warmed (53uC,
5 min), vortexed and incubated (53uC, 25 min). Samples were
subsequently cooled (to RT) and dried in vacuo. Deionized H2O
and petroleum ether/n-butanol/ethyl formate [4:20:1 (v/v)] were
then added, then the mixture vortexed and centrifuged (1000 g,
5 min). The upper organic phase was then removed, the lower
water-soluble phase mixed with 1 vol petroleum ether/n-butanol/
ethyl formate [4:20:1 (v/v)], and the mixture vortexed and
centrifuged as previously. The lower phase and interface was then
dried in vacuo. Labelled lipid species were then separated for
analysis by high-performance liquid chromatography (HPLC).
Dried lipids were resuspended in dH2O (2 ml; bath sonicated, and
vortexed) and filtered (0.45 mm). Samples were loaded onto a pre-
equilibrated Whatman Partisphere 5SAX column (12.5 cm) and
developed at 1 mlmin21 using a gradient of H2O (A) versus
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1.25 M NaH2PO4 (B) [0 min, 0% B; 1 min, 1% B; 30 min, 6% B;
31 min, 15% B; 60 min, 25% B; 61 min, 33% B; 80 min, 60% B;
81 min, 100% B]. Fractions were collected every 30 s and
scintillant added (Packard ‘Ultima Gold’). Lipid species were
identified from the elution profile by comparison to labelled
standards of known individual phosphoinositide species.
PI(5)P levels were assayed as described [42]. Briefly, cultured
cells were lysed into ice cold 5% (v/v) perchloric acid and
incubated on ice prior to centrifugation (5000g, 10 min, 4uC).
Lipids were extracted from the pellet using acidified chloroform/
methanol and an aliquot removed for phospholipid quantification
such that PI5P levels could be assessed relative to total cellular lipid
[42]. The remainder was dried and resuspended in 1 vol
CHCl3:CH3OH:ammonium formate [5:10:2 (v/v/v), final con-
centration 50 mM ammonium formate). This was added to 0.1 vol
neomycin beads [42] successively washed in 1 vol
CHCl3:CH3OH:H2O [5:10:2 (v/v/v)], CHCl3:CH3OH:ammo-
nium formate [5:10:2 (v/v/v), final concentration 0.5 M formate],
and finally resuspended in 0.1 vol CHCl3:MeOH:ammonium
formate [5:10:2 (v/v/v), final concentration 50 mM formate].
Samples were incubated (RT, 20 min), centrifuged (4000 g, 1min)
and the supernatant discarded. Beads were washed twice with
1 vol 50 mM ammonium formate buffer and lipids eluted twice
with 2 M triethylbicarbonate (TEAB) to which phosphatidylserine
was added as an inert carrier (14.25 mM). Beads were incubated
with 0.5 vol 2 M TEAB and phosphatidylserine (1 h), centrifuged
(4000 g, 2 min) and supernatants collected. Beads were washed
again with 0.2 vol 2 M TEAB and phosphatidylserine (1 h), and
supernatants combined with the first. Tubes were dried in vacuo
(60uC, overnight). Lipid phosphorylation with recombinant type
IIa phosphatidylinositol kinase to determine PI(5)P mass was
performed as previously [42]. Phosphorylation was initiated by
addition of 2 mCi [c-32P] ATP and 5 mM ATP to each sample,
and PI(4,5)P2 extracted and separated by thin layer chromatog-
raphy. PI(5)P levels were determined from a standard curved with
reference to known concentrations of synthetic PI(5)P, and
expressed relative to amount of total phospholipids present in
each sample.
Supporting Information
Figure S1 Characterization of S.typhimurium strains and cultured
cells exogenously expressing SipB and SipD. A. Effector
expression and secretion in S.typhimurium SL1344 wild-type
compared with strains transformed with pTrc plasmids expressing
SipB or SipD in trans in the wild-type background. Equivalent
loadings of late exponential cell lysates (left) and filtered culture
supernatants (right) were separated by SDS-PAGE and analyzed
by immunoblotting with the appropriate effector antibody or
RfaH (control). Densitometric analysis showed that plasmid-
encoded SipB and SipD expression was specifically augmented
in the absence of induction (,4-fold wild-type), and that elevated
expression correlated with increased effector secretion (,3-fold
wild-type). Effector expression from the plasmid did not interfere
with the expression or secretion of other chromosomally-encoded
entry effectors. B. Effect of exogenous SipB or SipD expression on
S.typhimurium entry into cultured fibroblasts. Results of gentamicin
protection assays using wild-type or strains exogenously expressing
SipB (dSipB) or SipD (dSipD). Entry rates (after 60 min) were
compared to wild-type (assigned as 100%) containing the empty
plasmid. Results are the mean of four independent experiments
each with three replications. Correspondingly, no significant
change was observed in mean cells invaded per field (wild-type
560.5, dSipB 561, dSipD 561; numbers of invaded cells were
scored in .30 cells in each of three independent experiments), or
in mean number of bacteria per fibroblast (wild-type 1.6560.1,
dSipB 1.4860.23, dSipD 1.060.28; bacteria were scored in .100
cells by inside/outside immunofluorescence staining in each of
three independent experiments. C. Immunofluorescence localiza-
tion of SipB and SipD in Salmonella-infected fibroblasts. Immuno-
fluorescence micrographs of fixed NIH3T3 cells after infection
(60 min) with Salmonella strains expressing augmented levels of
SipB or SipD as indicated. Left column shows triple fluorescence
(merge) of cells stained with anti-SipB or anti-SipD/Alexafluor
488-conjugated anti-rabbit IgG to localize each effector (green),
Texas Red-conjugated phalloidin to visualize F-actin (red), and
DAPI to localize cell nuclei and bacteria (blue). Middle column
shows individual effector channel (effector) and right column the
DAPI channel from which the nuclear signal has been removed for
clarity (indicated by dashed lines) (bacteria). Arrows indicate
internalized bacteria, and areas indicated in merge are show at
higher magnification in inserts. Scale bars, 2 mm. D. Immunoflu-
orescence micrograph of fixed NIH3T3 fibroblast transiently
expressing SipB. Left panel shows double fluorescence (merge)
image of cell SipB stained 48 h after transfection with anti-SipB
polyclonal antiserum/Alexafluor 488-conjugated anti-rabbit IgG
to localize SipB (green), and Texas Red-conjugated phalloidin to
visualize F-actin (red). SipB channel alone (effector) is shown in
greyscale for clarity. Image is typical of .50 cells from three
independent experiments. Scale bar, 2 mm. E. Localization of
SipB and SipD in Salmonella-infected and effector-transfected
fibroblasts. Cultured NIH3T3 fibroblasts were infected (60 min)
with S.typhimurium strains expressing augmented levels of SipB
(dSipB) or SipD (dSipD) in the wild-type background or were
transiently transfected (48 h) with an expression vector encoding
S.typhimurium SipB. Cells were mechanically fractionated (as [19]),
and each subfraction [nuclei+internalized bacteria (N+B), cyto-
skeleton and internal membranes (CS/IM), cytoplasm (C), plasma
membrane (PM)] separated by SDS-PAGE and analysed by
immunoblotting with anti-SipB or anti-SipD antibody. SipD was
below the detection threshold under these conditions.
Found at: doi:10.1371/journal.ppat.1000037.s001 (13.32 MB
TIF)
Figure S2 Intracellular effector concentration after T3SS-
dependent delivery and transfection. A. Cell number and viability
following transfection with Salmonella effectors. NIH3T3 fibroblasts
were individually transfected with indicated effectors and analyzed
by flow cytometry after 48 h. Cell number is expressed as the
percentage of control cells, with apoptotic fraction shaded black.
B. Effector concentration following delivery or transfection.
Upper: Cells transfected with effectors (t-effector) or infected with
effector-augmented (d-effector) S.typhimurium strains were mechan-
ically fractionated prior to immunoblotting with appropriate anti-
effector antibodies. Effector concentration in the internal mem-
brane/cytoskeletal (IM/CS) and plasma membrane (PM) fractions
was determined by densitometric analysis of band intensity and
comparison to purified protein standards (e.g. SipC and SopE). To
facilitate simultaneous quantification of effectors after transfection
and infection, fractions from 2.76106 and 5.46106 cells were
immunoblotted, respectively. Lower: Graph shows comparative
concentrations of each transfected and delivered effector. Split
bars represent relative concentration in the two subcellular
fractions (IM/CS lower division; PM upper division). C. Effector
localization following delivery and transfection. Cells transfected
with effectors (e.g. tSipC, tSipA, tSopE or tSptP) were infected with
effector-augmented (d-effector) S.typhimurium strains (e.g. dSipA,
dSipC, dSptP or dSopE). Infected transfectants were mechanically
fractionated, each sub-fraction [N+B cell nuclei+internalized
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bacteria; IM/CS internal membranes/cytoskeleton; C cytoplas-
mic; PM plasma membrane] separated by SDS-PAGE, and
analyzed by immunoblotting with the appropriate anti-effector
antibody.
Found at: doi:10.1371/journal.ppat.1000037.s002 (0.53 MB TIF)
Figure S3 The T3SS translocator SipB and SipD are not
invasion effectors. A. Schematic illustrating trans BENEFIT
screening (the infection of cells expressing individual entry effectors
by wild-type WT or effector-augmented S.typhimurium strains).
Wild-type (WT) bacteria endogenously express, secrete and deliver
sipA, sipC, sopE, sopB and sptP (abbreviated to acebp) and sipB and
sipD (abbreviated separately as bd). Effector-augmented strains
each express, secrete and deliver mildly increased levels of an
individual plasmid-encoded effector in the WT background
[enhanced effector shown in capitals, e.g. acebp Bd (dSipB) and
acebp bD (dSipD) produce increased levels of SipB and SipD,
respectively]. Cultured cells were transfected with individual entry
effectors (denoted t-effector) prior to infection. B. Upper: Cultured
fibroblasts were transfected (t) with individual effectors prior to
infection with WT or effector-augmented (d-effector) S.typhimurium
strains. Invasion rates after 60 min were compared to WT
(assigned as 100%). Results are mean6SEM of 4 independent
experiments each performed in triplicate. Baselines ‘wild-type’ and
‘DinvG’ denote S.typhimurium SL1344 and S.typhimurium DinvG
(T3SS deficient) invasion in each transfectant background,
respectively. Lower: Table showing differences in invasion rates
(%) after correction. Shading denotes a significant increase (green),
significant decrease (red) or no significant change (grey) in invasion
(Mann Whitney U p,0.05).
Found at: doi:10.1371/journal.ppat.1000037.s003 (9.10 MB TIF)
Figure S4 Actin rearrangements induced during infection of
transfected cells. Cultured fibroblasts were transfected with
indicated effectors (t-effector) and subsequently infected with
effector-augmented (d-effector) S.typhimurium strains. Cells were
fixed 60 min post infection and double fluorescence stained to
visualise F-actin and bacteria/cell nuclei. Arrows indicate
internalized bacteria.
Found at: doi:10.1371/journal.ppat.1000037.s004 (1.66 MB TIF)
Figure S5 Effector synergy is abolished by biasing the relative
levels of each strain. S.typhimurium SL1344 or effector augmented
(d-effector) strains were mixed pair wise (MOI 50) at 50:50, 90:10
and 10:90 ratios. Invasion of each strain was assessed using
selectable markers after 60 min (Figure 4A). Results are the mean
of four independent experiments each performed in triplicate. Pie
charts depict total invasion by each combination (size; combined
%) and relative contribution of each strain (division; %) using the
indicated ratios.
Found at: doi:10.1371/journal.ppat.1000037.s005 (0.69 MB TIF)
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